2 ) metoclopramide therapy for 4 wk is significantly more effective than placebo ( medium dose antacid therapy ) in relieving the symptoms of gastroesophageal reflux without significantly altering objective parameters of esophagitis ;
C0025853
metoclopramide
C0017168
gastroesophageal reflux